Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.250
+0.010 (0.81%)
At close: Nov 22, 2024, 4:00 PM
1.270
+0.020 (1.59%)
After-hours: Nov 22, 2024, 7:58 PM EST

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of $7.13 million. The enterprise value is $7.80 million.

Market Cap 7.13M
Enterprise Value 7.80M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date Nov 14, 2024
Ex-Dividend Date n/a

Share Statistics

BCLI has 5.70 million shares outstanding. The number of shares has increased by 69.79% in one year.

Current Share Class 5.70M
Shares Outstanding 5.70M
Shares Change (YoY) +69.79%
Shares Change (QoQ) +11.84%
Owned by Insiders (%) 0.83%
Owned by Institutions (%) 0.36%
Float 64.12M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.05

Current Ratio 0.05
Quick Ratio 0.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -35.02

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -215.84%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$490,621
Employee Count 29
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -62.09% in the last 52 weeks. The beta is 0.39, so BCLI's price volatility has been lower than the market average.

Beta (5Y) 0.39
52-Week Price Change -62.09%
50-Day Moving Average 2.24
200-Day Moving Average 5.24
Relative Strength Index (RSI) 27.48
Average Volume (20 Days) 121,342

Short Selling Information

The latest short interest is 109,802, so 1.93% of the outstanding shares have been sold short.

Short Interest 109,802
Short Previous Month 165,892
Short % of Shares Out 1.93%
Short % of Float 0.17%
Short Ratio (days to cover) 1.25

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -13.31M
Pretax Income -15.53M
Net Income -14.23M
EBITDA -13.06M
EBIT -13.31M
Earnings Per Share (EPS) -$3.19
Full Income Statement

Balance Sheet

The company has $168,000 in cash and $841,000 in debt, giving a net cash position of -$673,000 or -$0.12 per share.

Cash & Cash Equivalents 168,000
Total Debt 841,000
Net Cash -673,000
Net Cash Per Share -$0.12
Equity (Book Value) -6.06M
Book Value Per Share -1.14
Working Capital -6.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.33 million and capital expenditures -$18,000, giving a free cash flow of -$11.35 million.

Operating Cash Flow -11.33M
Capital Expenditures -18,000
Free Cash Flow -11.35M
FCF Per Share -$1.99
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -69.79%
Shareholder Yield -69.79%
Earnings Yield -199.57%
FCF Yield -159.17%

Analyst Forecast

The average price target for BCLI is $30.00, which is 2,300.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $30.00
Price Target Difference 2,300.00%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 1, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Oct 1, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1